Sequence Bioinformatics Inc. — Form D
Sequence Bioinformatics Inc. of ST. JOHNS, A4, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-30. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Other.
Offering
- Filed: 2019-07-30
- Form: D
- Accession: 0001679588-19-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.3M
- Investors: 2
- Date of first sale: 2019-07-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-345408
Issuer
- Name: Sequence Bioinformatics Inc.
- CIK: 0001679588
- Entity type: Corporation
- Jurisdiction: NEWFOUNDLAND, CANADA
- Incorporated: 2013
- Address: 139 WATER STREET, ST. JOHNS, A4, A1C 1B2
- Phone: 1-709-689-0851
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| MARK DOBBIN | Director | ST. JOHN'S, A4 |
| ANDREW FUREY | Director | ST. JOHNS, A4 |
| Chris Gardner | Director | Anaheim, CA |
| James Hardiman | Director | SOUTH SAN FRANCISCO, CA |
| Chris Gardner | Executive Officer | Anaheim, CA |
| Chris Gardner | Promoter | Anaheim, CA |
| Tyler Wish | Director | St. John's, A4 |
| Tyler Wish | Executive Officer | St. John's, A4 |
Other filings by this issuer (1)
More